Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong · Delayed Price · Currency is HKD 4.000
0.00 (0.00%)
At close: Nov 2, 2026
Wuhan YZY Biopharma Market Cap
Wuhan YZY Biopharma has a market cap or net worth of 775.4 million as of November 2, 2026. It is the 25,083rd most valuable company in the world and the 1,208th biggest in Hong Kong. Its market cap has decreased by 42.94% in one year.
Market Cap
775.40M
Enterprise Value
847.72M
Revenue
67.26M
Global Rank
Country Rank
#1,208 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since September 25, 2023, Wuhan YZY Biopharma's market cap has decreased from 3.09B to 775.40M, a decrease of -74.89%. That is a compound annual growth rate of -35.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 775.40M | -50.12% |
| Dec 31, 2025 | 1.55B | -3.14% |
| Dec 31, 2024 | 1.61B | -6.97% |
| Dec 29, 2023 | 1.73B | -44.13% |
| Sep 25, 2023 | 3.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.28B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.20B |
| TYK Medicines | 1.13B |
| Zhaoke Ophthalmology | 1.10B |
| Cloudbreak Pharma | 1.10B |
| CANbridge Pharmaceuticals | 1.03B |
| Sunho Biologics | 970.43M |
| JW (Cayman) Therapeutics Co. | 905.15M |